How Blood Clotting Works: Sealing a Wound From the Inside

A minor kitchen cut stops bleeding within a few minutes without any conscious effort on your part, a process that looks simple from the outside but actually runs through a tightly sequenced biological cascade involving dozens of proteins that have to activate in the right order, at the right time, in the right place. Get that sequence wrong in one direction and a person bleeds excessively from a minor injury; get it wrong in the other direction and clots form where they shouldn't, inside blood vessels that were never injured, with dangerous consequences.

The first response: platelets plug the gap

The instant a blood vessel wall is damaged, it exposes collagen fibers normally hidden safely beneath the vessel's inner lining. Platelets, small cell fragments that circulate through blood in enormous numbers specifically for this purpose, recognize that exposed collagen and stick to it within seconds, a step called adhesion. Once attached, platelets release chemical signals that recruit more platelets to the site and cause them to change shape, sprouting sticky projections that let them clump together with each other, forming a loose plug that quickly slows the bleeding, a stage doctors call primary hemostasis. This platelet plug is fast but fragile on its own, roughly comparable to a temporary patch, which is why the second stage of clotting exists to lock it in permanently.

The coagulation cascade: proteins activating proteins

Running in parallel with the platelet response is a chain reaction involving roughly a dozen clotting factors, proteins that normally circulate in an inactive form throughout the blood. Damage to a vessel triggers the first factor in the chain to activate, and each activated factor then activates the next one in line, an arrangement called a cascade specifically because each step amplifies the next, turning a small initial signal into a large final effect very quickly. The cascade's endpoint is the conversion of a soluble protein called fibrinogen into fibrin, which unlike its precursor is not soluble and instead forms long, sticky strands that weave into a mesh, trapping red blood cells and reinforcing the loose platelet plug into a much sturdier structure: a proper blood clot, also called a thrombus when it forms inside a vessel.

Why missing one factor breaks the whole system

Because each step in the cascade depends on the one before it, missing or malfunctioning even a single clotting factor can prevent the entire chain from completing properly, regardless of how well every other factor works. This is precisely the underlying problem in hemophilia, a genetic condition in which one specific clotting factor, most commonly factor VIII or factor IX, is deficient or absent, meaning the cascade stalls partway through and a stable fibrin mesh never fully forms, leaving affected individuals prone to prolonged bleeding from injuries that would clot normally in most people, and to spontaneous internal bleeding into joints and tissues without any obvious injury at all. Treatment typically involves infusing the missing factor directly, temporarily restoring the cascade's ability to complete.

Vitamin K and why blood thinners target this system

Several clotting factors can only be produced by the liver in a functional form with the help of vitamin K, which is why a vitamin K deficiency, though uncommon in adults with a typical diet, can impair clotting, and why newborns, who start life with very low vitamin K stores, routinely receive a vitamin K injection shortly after birth as a preventive measure. This same vitamin K dependency is also the target of warfarin, a widely prescribed blood thinner that works by blocking the liver's ability to activate vitamin K-dependent clotting factors, deliberately slowing the cascade in patients at risk of dangerous clots, such as those with certain irregular heart rhythms. Newer blood thinners work differently, directly blocking a single specific factor partway through the cascade rather than interfering with vitamin K broadly.

The brakes: why clots don't spread everywhere

A clotting cascade that only ever amplified itself would be catastrophic, eventually clotting all the blood in the body from a single small injury, so the body runs a parallel set of natural anticoagulant proteins, including one called antithrombin, that actively restrain the cascade and confine clot formation to the immediate area of injury. Once a wound has healed, a separate system called fibrinolysis breaks the fibrin mesh back down, dissolving the clot as it's no longer needed. When either of these braking systems fails, or when a clot forms inside an undamaged vessel due to factors like prolonged immobility or an underlying clotting disorder, the result can be a dangerous blockage: a deep vein thrombosis in a leg, or a clot that travels to the lungs, heart, or brain, which is why understanding clotting isn't purely about wound healing but also about preventing thrombosis, one of the most common preventable causes of death in hospitalized patients.